Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

ADAMTSL1基因的种系变异与年轻女性乳腺癌治疗后的预后相关

阅读:2

Abstract

To identify genetic variants associated with breast cancer prognosis we conduct a meta-analysis of overall survival (OS) and disease-free survival (DFS) in 6042 patients from four cohorts. In young women, breast cancer is characterized by a higher incidence of adverse pathological features, unique gene expression profiles and worse survival, which may relate to germline variation. To explore this hypothesis, we also perform survival analysis in 2315 patients aged ≤ 40 years at diagnosis. Here, we identify two SNPs associated with early-onset DFS, rs715212 (P (meta) = 3.54 × 10(-5)) and rs10963755 (P (meta) = 3.91 × 10(-4)) in ADAMTSL1. The effect of these SNPs is independent of classical prognostic factors and there is no heterogeneity between cohorts. Most importantly, the association with rs715212 is noteworthy (FPRP <0.2) and approaches genome-wide significance in multivariable analysis (P (multivariable) = 5.37 × 10(-8)). Expression quantitative trait analysis provides tentative evidence that rs715212 may influence AREG expression (P (eQTL) = 0.035), although further functional studies are needed to confirm this association and determine a mechanism.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。